Biora Therapeutics (NASDAQ:BIOR) Shares Down 11.6% – Should You Sell?

Shares of Biora Therapeutics, Inc. (NASDAQ:BIOR) dropped 11.6% during mid-day trading on Monday . The stock traded as low as $0.42 and last traded at $0.53. Approximately 18,311 shares traded hands during trading, a decline of 68% from the average daily volume of 57,403 shares. The stock had previously closed at $0.60.

Analysts Set New Price Targets

Separately, HC Wainwright upped their price target on Biora Therapeutics from $15.00 to $23.00 and gave the stock a “buy” rating in a research note on Monday, November 18th.

Biora Therapeutics Stock Performance

The stock has a market cap of $2.13 million, a PE ratio of -0.04 and a beta of 1.12. The firm has a 50-day moving average price of $2.37 and a 200-day moving average price of $5.01.

Biora Therapeutics Company Profile

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.